GH1 and melanoma: Keeping in view the cumulative information from earlier research in the field of GH and cancer [14,76] as well as our current findings, combined GHR antagonism appears to offer a method of making radiotherapy, chemotherapy, as well as specific targeted therapies more efficacious not only in melanoma, but also in other solid tumors which overexpress the GHR.